Status:
COMPLETED
Effectiveness of Brainwave Biofeedback in the Treatment of Fibromyalgia
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine whether a new form of brainwave biofeedback is effective in the treatment of fibromyalgia.
Detailed Description
Fibromyalgia (FM) is a chronic disorder that involves chronic widespread musculoskeletal pain typically accompanied by fatigue, disordered sleep, cognitive complaints, psychological distress, and impa...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Diagnosis of fibromyalgia with symptoms for at least 1 year
- Self-report of having attention/concentration, memory, multi-tasking or other thinking difficulties
- Able to read and understand English
- Able to attend treatment sessions weekly and return for planned follow-ups
- Appropriate balance of average delta (\<4 Hertz) EEG waveband and alpha (approximately 4-8 Hertz) EEG waveband amplitude on LENS screening (to be determined by study personnel);
- Exclusion criteria:
- Other chronic pain condition of major significance
- Current chronic viral infection
- Current other unstable medical condition
- History of spinal, including neck, surgery
- Psychological screening indicates psychotic, suicidal, homicidal, and/or substance abusing
- Use of long-acting opioid medication taken on a continuous 24-hour dosing schedule
- Current involved in litigation regarding pain condition or seeking disability
- History of electroconvulsive therapy
Exclusion
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00080184
Start Date
December 1 2003
End Date
May 1 2006
Last Update
August 18 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239-3098